Corvus Pharmaceuticals
CRVS
CRVS
49 hedge funds and large institutions have $62.8M invested in Corvus Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+11
Holders Change %
+28.95%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
16
Reduced
8
Closed
8
Calls
$93K
Puts
$462K
Net Calls
-$369K
Net Calls Change
-$586K
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$9.95M |
| 2 |
O
2
OrbiMed
New York
|
$24.8M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$3.08M |
| 4 |
4
Two Sigma Investments
New York
|
$1.07M |
| 5 |
5
Bank Julius Baer & Co
Zurich,
Switzerland
|
$1.04M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Russell Investments Group
London,
United Kingdom
| – | -$120K | -34,117 | Closed |
|
52
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$121K | -33,968 | Closed |
|
|
GG
53
Golden Green
Seneca,
South Carolina
| – | -$70K | -19,539 | Closed |
|
54
Capstone Investment Advisors
New York
| – | -$63K | -17,776 | Closed |
|
|
FPCG
55
Fort Pitt Capital Group
Pittsburgh,
Pennsylvania
| – | -$2K | -500 | Closed |
|
56
BNP Paribas Financial Markets
Paris,
France
| – | -$14 | -4 | Closed |
|